small molecule

ESTRACE

ESTRADIOL

Loss of exclusivityloss of exclusivity
CompanyAbbVie Inc.See this company's full patent-cliff portfolio

Drug detail

Brand nameESTRACE
Active ingredientESTRADIOL
Strength0.01%
Dosage formCREAM
RouteVAGINAL
ModalitySmall molecule
FDA approvalJanuary 1984
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ESTRACE patent cliff — loss of exclusivity — | CliffBio